PROTAC’ing oncoproteins: targeted protein degradation for cancer therapy

Overview of attention for article published in Molecular Cancer, March 2023

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (61st percentile)
Above-average Attention Score compared to outputs of the same age and source (56th percentile)

So far, Altmetric has seen 6 X posts from 6 X users, with an upper bound of 6,780 followers.

RT @Glaconde34: PROTAC’ing oncoproteins: targeted protein degradation for cancer therapy 📚Open Access https://t.co/tqLZmjNwos

RT @Glaconde34: PROTAC’ing oncoproteins: targeted protein degradation for cancer therapy 📚Open Access https://t.co/tqLZmjNwos

RT @Glaconde34: PROTAC’ing oncoproteins: targeted protein degradation for cancer therapy 📚Open Access https://t.co/tqLZmjNwos

RT @Glaconde34: PROTAC’ing oncoproteins: targeted protein degradation for cancer therapy 📚Open Access https://t.co/tqLZmjNwos

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.